iRhythm Holdings, Inc. (IRTC)

NasdaqGS · Medical Devices

106.68
-0.02 (-0.02%)
Updated Oct 13, 4:37 AM ET
AI Rating
Strong Sell
Overall Score
28
Trend
3
Momentum
28
Risk
69

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Sep 29, 2025 260 sessions Oct 9, 2026

AI Analysis

iRhythm Holdings, Inc. is trading at $106.68, down 0.02% on the session. The 50 day average sits at $117.41 and the 200 day at $126.96, which puts the stock in a downtrend. RSI is at 40.1, which reads as weak, and MACD is bearish crossover. Volume is average.

The nearest support is around $105.28 with resistance near $114.84, so that band frames the current range. Average daily movement is roughly $4.35, or about 4.1% of the share price, which is what any stop placement has to allow for. The overall health score of 28 out of 100 combines a trend score of 3, momentum of 28 and a risk score of 69.

Technical indicators

RSI (14)
40.1
weak
MACD
-3.019
bearish crossover
SMA 20
110.29
SMA 50
117.41
SMA 200
126.96
downtrend
ATR (14)
4.35
avg daily range
Support
105.28
Resistance
114.84
Volume vs 20d
1.01x
average
Volatility
28.9%
annualised
1 month
-5.48%
3 months
-10.09%

About iRhythm Holdings, Inc.

iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with BioIS to develop and commercialize pulse oximetry, accelerometry, and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring products and services. The company was formerly known as iRhythm Technologies, Inc. and changed its name to iRhythm Holdings, Inc. in January 2026. iRhythm Holdings, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.

Company website

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.